The Role of Small Molecules in Musculoskeletal Regeneration
- 20 July 2012
- journal article
- review article
- Published by Taylor & Francis in Regenerative Medicine
- Vol. 7 (4) , 535-549
Abstract
The uses of bone morphogenetic proteins and parathyroid hormone therapeutics are fraught with several fundamental problems, such as cost, protein stability, immunogenicity, contamination and supraphysiological dosage. These downsides may effectively limit their more universal use. Therefore, there is a clear need for alternative forms of biofactors to obviate the drawbacks of protein-based inductive factors for bone repair and regeneration. Our group has studied small molecules with the capacity to regulate osteoblast differentiation and mineralization because their inherent physical properties minimize limitations observed in protein growth factors. For instance, in general, small molecule inducers are usually more stable, highly soluble, nonimmunogenic, more affordable and require lower dosages. Small molecules with the ability to induce osteoblastic differentiation may represent the next generation of bone regenerative medicine. This review describes efforts to develop small molecule-based biofactors f...Keywords
Funding Information
- Research and Education Foundation
- NSF-EFRI (0736002, NIH-R21AR060480)
This publication has 182 references indexed in Scilit:
- Integration of BMP, Wnt, and notch signaling pathways in osteoblast differentiationJournal of Cellular Biochemistry, 2011
- The small molecule PKA-specific cyclic AMP analogue as an inducer of osteoblast-like cells differentiation and mineralizationJournal of Tissue Engineering and Regenerative Medicine, 2011
- Psoralen stimulates osteoblast differentiation through activation of BMP signalingBiochemical and Biophysical Research Communications, 2011
- Osthole stimulates osteoblast differentiation and bone formation by activation of β-catenin–BMP signalingJournal of Bone and Mineral Research, 2010
- Oxysterol‐induced osteogenic differentiation of marrow stromal cells is regulated by Dkk‐1 inhibitable and PI3‐kinase mediated signalingJournal of Cellular Biochemistry, 2008
- Sustained release of sphingosine 1-phosphate for therapeutic arteriogenesis and bone tissue engineeringBiomaterials, 2008
- Recognizing and exploiting differences between RNAi and small-molecule inhibitorsNature Chemical Biology, 2007
- Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal fusionInternational Orthopaedics, 2007
- A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE® Bone Graft)International Orthopaedics, 2007
- Purmorphamine activates the Hedgehog pathway by targeting SmoothenedNature Chemical Biology, 2005